Pancreatic Cancer Research

ResearcherPhilipps University of MarburgActive in the last 2 years

Elmar Wolf

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5299-6335; OpenAlex author ID A5081972858. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 6

  1. Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-026-69013-y↗
  2. Pharmacological arginine deprivation renders pancreatic cancer cells susceptible to senolysis and inhibition of the integrated stress response Co-author DOI 10.64898/2026.08.03.740778↗
  3. Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. Last author DOI 10.1136/gutjnl-2023-331519↗
  4. NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2105691119↗
  5. MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-21-1677↗
  6. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Co-author DOI 10.1158/2159-8290.cd-13-0593↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martin Eilers · 4 shared papers, 2014–2026 · strength 0.54
  2. Mathias Tillmann Rosenfeldt · 3 shared papers, 2021–2026 · strength 0.51
  3. Markus Vogt · 2 shared papers, 2024–2026 · strength 0.36
  4. Laura Mainz · 1 shared paper, 2026 · strength 0.24
  5. Almut Schulze · 1 shared paper, 2026 · strength 0.24
  6. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.24
  7. Jens Thomas Siveke · 2 shared papers, 2014–2026 · strength 0.23
  8. Sven‐Thorsten Liffers · 1 shared paper, 2026 · strength 0.20
  9. Diana Behrens · 1 shared paper, 2026 · strength 0.20
  10. Juanfei Peng · 1 shared paper, 2026 · strength 0.20
  11. Phyllis F. Cheung · 1 shared paper, 2026 · strength 0.20
  12. Marija Trajkovic‐Arsic · 1 shared paper, 2026 · strength 0.20
  13. Barbara T. Grünwald · 1 shared paper, 2026 · strength 0.20
  14. Niklas Krebs · 1 shared paper, 2026 · strength 0.20
  15. Laura Godfrey · 1 shared paper, 2026 · strength 0.20
  16. Rita Teresa Lawlor · 1 shared paper, 2026 · strength 0.20
  17. Rickmer Braren · 1 shared paper, 2026 · strength 0.20
  18. Aldo Scarpa Scarpa · 1 shared paper, 2026 · strength 0.20
  19. Dieter Saur · 1 shared paper, 2024 · strength 0.16
  20. Iréne Esposito · 2 shared papers, 2014–2022 · strength 0.15
  21. Josefina Doffo · 1 shared paper, 2022 · strength 0.12
  22. Felix Orben · 1 shared paper, 2022 · strength 0.12
  23. Ulrich Bernd Keller · 1 shared paper, 2022 · strength 0.12
  24. Maximilian Reichert · 1 shared paper, 2022 · strength 0.12
  25. Oliver Holger Krämer · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.